Shift Work Disorder Trial

SUNOSI® (Solriamfetol) Study for

Shift Work Sleep Disorder

Working nights or rotating shifts and struggling to stay awake?

You may qualify for a clinical research study evaluating SUNOSI® (solriamfetol), an FDA-approved medication being studied to help people with Shift Work Sleep Disorder (SWSD) improve wakefulness during their work hours.

Shift Work Sleep Disorder can affect people who work non-traditional hours, leading to:

  • Excessive sleepiness during night shifts

  • Difficulty staying alert on the job

  • Fatigue that impacts performance and safety

This study is evaluating whether SUNOSI® may help:

  • Improve wakefulness during scheduled work hours

  • Reduce excessive daytime or nighttime sleepiness

  • Support better functioning during shift-based schedules

You may qualify if you:

  • Work overnight, early morning, or rotating shifts

  • Regularly experience trouble staying awake during work hours

  • Are otherwise generally healthy or meet study-specific criteria

What to expect:

  • Study medication (SUNOSI® or placebo)

  • Wakefulness and sleep assessments

  • Regular visits with a clinical research team

Participants receive:

  • Study-related care at no cost

  • Close monitoring by medical professionals

  • Compensation for time and travel

Why participate?

  • Access to a medication already approved for other sleep disorders, now being studied for SWSD

  • Opportunity to improve alertness during work hours

  • Help advance research for people working non-traditional schedules

Interested? Email us at research@tricoastalsleep.com or click here.